Zetonna

Active Ingredient(s): Ciclesonide
FDA Approved: * January 20, 2012
Pharm Company: * NYCOMED GMBH
Category: Allergies, Cough & Cold

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zetonna Overview

Ciclesonide is a glucocorticoid used to treat asthma and allergic rhinitis. It is marketed under the brand names Alvesco for asthma and Omnaris, Omniair, and Zetonna for hay fever in the US and Canada. Phase 3 trials for the hay fever indication outside the US are ongoing.[1] The drug was approved for adults and children 12 and over by the US Food and Drug Administration in October 2006.[2] Side effects of the medication include headache, nosebleeds, and inflam...

Read more Zetonna Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ciclesonide

Recent Zetonna Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ciclesonide
  • Aerosol: 74mcg
  • Aerosol, Metered: 0.037mg/inh, 0.08mg/inh, 0.16mg/inh, 80mcg
  • Spray: 50mcg
  • Spray, Metered: 0.05mg/inh
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zetonna: (2 results)

Sorted by National Drug Code
  • 63402-737 Zetonna 37 ug/1 Nasal Aerosol, Metered by Sunovion Pharmaceuticals Inc.
  • 70515-737 Zetonna 37 ug/1 Nasal Aerosol, Metered by Covis Pharma

Other drugs which contain Ciclesonide or a similar ingredient: (3 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA